Skip to content
Screener

ResMed RMD Equity Method Income

Equity Method Income at other companies

Five Point Holdings, Inc. logo
Five Point Holdings, Inc.FPH
$41.03M+139%

Other financials

Income statement

See full
Revenue$1.5B+8.6%
Gross profit$861.2M+5.0%
Operating income$448.7M-1.3%
Net income$383.4M+1.0%
EPS (diluted)$2.64+2.3%

Balance sheet

See full
Cash & equivalents$1.5B+21.5%
Total debt$825.9M-4.2%
Total equity$6.6B+10.3%
Total assets$9.0B+9.7%

Cash flow

See full
Operating cash flow$454.6M-15.6%
CapEx$51.1M+67.2%
Free cash flow$403.5M-20.6%

Valuation

See full
Market cap$31.92B-23.3%
Enterprise value$31.28B-24.2%
P/E21×-8.8×
P/S5.7×-2.4×

Profitability

See full
Gross margin61.1%+1.7pp
Operating margin33.4%+0.6pp
Net margin26.9%-0.3pp
FCF margin29.2%-3.1pp

Returns & leverage

See full
Return on equity24.3%-1.6pp
Debt / equity0.1×0.0×
Current ratio3.1×-0.3×

Where this comes from

Reported directly by ResMed in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestments.

The source filing: ResMed’s 8-K, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 4:05 PM EDT
Accession
0001193125-26-337962

FAQ

What is ResMed's equity method income?
ResMed (RMD) reported equity method income of $2.23M in Q2 2026.
How has ResMed's equity method income changed year-over-year?
ResMed's equity method income increased by 75.9% year-over-year, from $1.27M to $2.23M.
What is the long-term trend for ResMed's equity method income?
Over 3 years (2022 to 2026), ResMed's equity method income has grown at a -6.4% compound annual growth rate (CAGR), from -$8.49M to $6.95M.
What does equity method income mean?
The company's proportional share of net income or loss from unconsolidated affiliates and joint ventures accounted for under the equity method.

Ask your AI about ResMed's equity method income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude